Abstract: Described herein is a method comprising performing optical character recognition on at least one region of a display screen to determine at least one displayed character; identifying, from the determined at least one displayed character, a monetary value to be dispensed; and in response to identifying the monetary value to be dispensed, causing to be dispensed at least one money item corresponding to the identified monetary value. Further described is a method comprising determining, using at least one money item denominating apparatus, a monetary value of at least one received money item; in response to determining the monetary value, automatically providing at least one simulated user input to the interactive user interface indicative of the determined monetary value.

Abstract: A connector product comprises a conduit connected to a device, a connector for connecting the conduit to a device, and a device having a port for connection to a conduit.

Abstract: A urinary catheter product comprises a urinary catheter connect to a bag, a connector for connecting the urinary catheter to a bag, and a bag having a port for connection to a urinary catheter.

Abstract: Provided herein are compounds and compositions that inhibit telomerase and/or the TERT gene with a mutant promoter. Further provided are small molecule compounds or compositions having beneficial effects in cancer treatment. Methods of making the compounds and compositions and methods of using the compounds and compositions, such as using the compounds and compositions to treat cancer, are also provided.

Abstract: Described herein is a method comprising performing optical character recognition on at least one region of a display screen to determine at least one displayed character; identifying, from the determined at least one displayed character, a monetary value to be dispensed; and in response to identifying the monetary value to be dispensed, causing to be dispensed at least one money item corresponding to the identified monetary value. Further described is a method comprising determining, using at least one money item denominating apparatus, a monetary value of at least one received money item; in response to determining the monetary value, automatically providing at least one simulated user input to the interactive user interface indicative of the determined monetary value.

Abstract: Described herein is a method comprising performing optical character recognition on at least one region of a display screen to determine at least one displayed character; identifying, from the determined at least one displayed character, a monetary value to be dispensed; and in response to identifying the monetary value to be dispensed, causing to be dispensed at least one money item corresponding to the identified monetary value. Further described is a method comprising determining, using at least one money item denominating apparatus, a monetary value of at least one received money item; in response to determining the monetary value, automatically providing at least one simulated user input to the interactive user interface indicative of the determined monetary value.

Abstract: Exemplary embodiments provide systems, devices and methods for simultaneously measuring mechanical and electrophysiological tissue responses (e.g., contractile function, or the like).

Abstract: Described herein is a method comprising performing optical character recognition on at least one region of a display screen to determine at least one displayed character; identifying, from the determined at least one displayed character, a monetary value to be dispensed; and in response to identifying the monetary value to be dispensed, causing to be dispensed at least one money item corresponding to the identified monetary value. Further described is a method comprising determining, using at least one money item denominating apparatus, a monetary value of at least one received money item; in response to determining the monetary value, automatically providing at least one simulated user input to the interactive user interface indicative of the determined monetary value.

Abstract: Exemplary embodiments provide systems, devices and methods for simultaneously measuring mechanical and electrophysiological tissue responses (e.g., contractile function, or the like).

Abstract: Compounds that may be used to inhibit Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting bone.

Abstract: The present invention provides heterocyclic derivatives which activate the IP receptor, processes for preparing them, pharmaceutical compositions comprising said derivatives and uses thereof. Activating the IP receptor signaling pathway is useful to treat many forms of PAH, pulmonary fibrosis and exert beneficial effects in fibrotic conditions of various organs in animal models and in patients.

Abstract: Compounds that may be used to inhibit Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting bone.

Abstract: A system and method for conducting a multi-player wagered networked bingo game. The system comprises a game controller operatively connected to at least two client devices. The game controller is preferably programmed to operate the networked bingo game and form patterns on a playing pieces associated with each client device. The game controller is preferably programmed to compare a plurality of intermediate patterns on each playing piece associated with each client device to determine if one of the intermediate patterns from the playing piece on at least two different client devices identically matches. The game controller can also be programmed to award an intermediate prize to each client device with the identically matched intermediate pattern and to conclude the networked bingo game when at least one pattern on the playing piece of at least one client device matches a game ending pattern.

Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4, R5, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.

Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.